semaglutide trial adolescents obesity 2022 Weight loss in the STEP trials with semaglutide. Data represent the Frontiers | Case report: Long-term

If you are also looking for broader background on GLP-1 support, our article on what GLP-1 support means for weight loss is a good companion piece

Again, it may be that people who have more severe diabetes or obesity are more likely to take semaglutide over a different medication

Your hypothalamusthe brain region controlling appetitedoesn't instantly recalibrate when medication stops

This initial dose allows your body to adjust to the medication while minimizing common side effects like nausea or vomiting

GLP-1 RAs: GLP-1 receptor agonists

3) Appetite feels more steady Instead of extreme hunger swings, some people report a more even appetite rhythmlike they can go from meal to meal without feeling frantic